INTRODUCTION
sure of central obesity, and skinfold thicknesses were used to derive a truncal to peripheral fat ratio and an upper to lower body-fat ratio.
After the subject consumed an ad libitum meal between 5:00 PM and 6:00 PM, venous blood was sampled between 10:00 PM and 11:00 PM. Blood was again sampled between 7:00 AM and 8:00 AM the next morning after an overnight fast. Leptin was assayed using an ELISA (Quantikine Human Leptin Immunoassay, R&D Systems, Minneapolis, MN).
An in-laboratory overnight sleep study was performed using the Compumedics E Series System (Abbotsville, Australia). Studies were manually scored using standard criteria. 20, 21 OSA severity was assessed with apnea-hypopnea index (AHI), arousal index, mean oxyhemoglobin saturation, and percentage of time spent below 90% saturation. AHI and arousal index were defined as the mean number of respiratory events and cortical arousals, respectively, per hour of sleep. Total sleep time and sleep-stage-specific times were also recorded.
Because of their skewed distribution, all sleep and leptin variables were log transformed prior to further analysis. The outcome in initial analyses was AHI, and the primary explanatory variables were the serum leptin concentrations and the evening to morning leptin ratio. These relationships were first evaluated by examining the distributions of leptin levels across AHI quartiles. Age-, sex-, and race-adjusted values were obtained using linear mixed models to account for familial correlation. Additional models also adjusted for BMI. The leptin-OSA relationship was also explored with AHI as a continuous outcome. Demographic, obesity, and leptin measures were assessed as predictors of AHI using a stepwise algorithm to generate the best multivariable linear mixed model. Differential effects between men and women and between European Americans and African Americans were investigated through the use of interaction terms as well as stratified analyses. Similar modeling was performed with the evening/morning leptin ratio as the dependent variable. Demographic, obesity, blood pressure, and sleep-related measures were included as potential predictors in this analysis. Quadratic and quartile-based models were developed for each predictor to assess for nonlinear effects. A threshold of P = .05 was used to assess statistical significance in all modeling. All analyses were conducted with SAS version 8.2 (SAS, Inc., Cary, NC).
RESULTS

Population Characteristics
A total of 161 individuals over the age of 16 years were studied. Twenty-three individuals receiving continuous positive airway pressure therapy at the time of the study were excluded, leaving a sample of 138 subjects. Four individuals were missing either the morning or evening leptin level and another 10 individuals had a leptin level that was either above or below the assay-detection level. The latter group was included in quartile-based analyses of the OSA-leptin association but not in analyses studying quantitative changes in leptin levels. Demographic and anthropometric data of the 138 subjects are shown in Table 1 . Using disease definitions of AHI ≥ 5, 10, and 15 events per hour, the frequency of OSA was 54%, 43%, and 30%, respectively. The mean AHI was 6.9 events per hour, with a wide range of severity (0-106). The majority of subjects (n = 109; 79%) were recruited from an index family (ie, with a family member with laboratory-diagnosed OSA). The cohort was balanced with respect to both sex and race. Overall, the population was overweight (mean BMI = 32.2 kg/m 2 ), with elevated waist-hip ratios, suggesting a high degree of central obesity. As expected, the AHI was greater in men than women. BMI, percent body fat, and total body fat, however, were highest among African American women. The overall mean leptin concentrations were 23.7 ng per mL in the morning and 23.5 ng per mL in the evening, and varied by both sex and race, with the highest levels observed among African American women. As expected, there was a strong correlation between leptin levels and both BMI and waisthip ratio quartile (P ≤ .01) in age-, sex-, and race-adjusted analyses ( Table 2 ). The evening/morning leptin ratio also increased with increasing BMI (P = .01), but no relationship was found between the leptin ratio and waist-hip ratio.
Models Predicting AHI
In age-, sex-, and race-adjusted analyses, morning and evening leptin levels were each strongly associated in a linear fashion with AHI quartile (P = .01 and P = .001, respectively). After adjusting for BMI, however, this association was no longer seen ( Values are mean ± SD except for all sleep and leptin measures, which are expressed as geometric mean and range. BMI refers to body mass index; Neck, neck circumference; AHI, apnea-hypopnea index. and race-adjusted analyses of the evening to morning leptin ratio across AHI quartiles indicated that the ratio was significantly greater for individuals in the highest AHI quartile compared to individuals in the lower 3 quartiles. This pattern remained after additional adjustment for BMI such that an AHI in the top quartile (AHI > 18.7) was significantly associated with a greater leptin ratio (P = .047). Similar results were found in modeling AHI as a continuous variable. After controlling for age, sex, and race, the measure of obesity that most closely correlated with AHI was BMI (P < .0001). As in the previous analyses, the correlation between AHI and either morning or evening leptin level was strong (P < .0001) in multivariable modeling controlling for age, sex, and race. However, after controlling for BMI, this association disappeared. These findings were confirmed in models that categorized leptin concentrations into quartiles (data not shown).
On the other hand, similar to the analysis of AHI expressed as quartiles, the evening to morning leptin ratio remained significantly associated with the continuous measure of AHI even after controlling for potential confounders, including obesity measures (P = .02); a 1-SD increase in the leptin ratio predicted a 17.7% increase in AHI. This relationship was similar in women and men. A 1-SD increase in the leptin ratio predicted a 16.8% increase in AHI among women and a 20.4% increase among men (P = .83 for difference). The other variables that were independently predictive of AHI were age, sex, and BMI (Table 4) . Based on the final multivariable model, the predicted AHI increases by 37.4% for each additional decade of age, by 73.3% for men, and by 7.2% for each additional kg/m 2 of BMI. Waist-hip ratio was of borderline significance (P = .06), and including it in the multivariate model did not substantially affect the relationship between leptin ratio and AHI (a 15.9% increase in AHI for a 1-SD increase in leptin ratio). Although African Americans had more severe OSA than European Americans, African American ethnicity was not associated with a greater AHI after controlling for differences in the other covariates. In addition, the association between the evening/morning leptin ratio and AHI was not significantly different between the 2 races.
Models Predicting Leptin Ratio
An increased AHI (P < .0001), a reduced mean overnight oxygen saturation (P = .009), and increased percentage of time spent below 90% oxygen saturation (P = .003) were significantly associated with an elevated evening/morning leptin ratio in univariate analyses. The relationship between AHI and leptin ratio appeared nonlinear, with a sharp rise in the leptin ratio among those in the highest quartile of AHI ( Figure  1 ). Further sensitivity analyses suggested that the threshold for an increased evening/morning leptin ratio occurs at an AHI of 15, with visual inspection of quantile-based analyses suggesting no evidence for a further rise above this AHI. The best obesity-related predictor of an increased leptin ratio was the amount of body fat (P = .0008). Age, sex, race, smoking status, blood pressure, hypertension status, and diabetes status had no predictive value in univariate analyses. In multivariable analyses, AHI, modeled either as a linear variable or a dichotomous variable with a cutoff at 15, had a stronger association to leptin ratio than did all other sleep measures including the 2 oxygenation indices. After controlling for body fat, AHI remained significantly associated with the leptin ratio (P = .001) such that an AHI above 15 was associated with a 23% increase in the evening/morning leptin ratio. No other measure was independently predictive of the leptin ratio in multivariable modeling. The relationship between AHI and evening/morning leptin ratio was not substantively altered by the addition of BMI, waist-hip ratio, and neck circumference as covariates, suggesting the association is independent of obesity and pattern of fat distribution. An AHI greater than 15 predicted a 32% increase in leptin ratio among women, which was not significantly different from the 25% increase observed among men (P = .56). Similarly, no significant difference was found between European Americans and African Americans.
DISCUSSION
We observed in the Cleveland Family Study that morning and evening leptin levels are strongly associated with AHI; however, these associa- Apnea-hypopnea index predictors assessed were age, sex, race, pack-years of smoking, body mass index, waist-hip ratio, neck circumference, percent body fat, total body fat, sum of skinfold thicknesses, sum of central skinfold thicknesses, truncal to peripheral fat ratio, upper to lower body fat ratio, morning leptin, evening leptin, and evening/morning leptin ratio. tions were explained by differences in obesity. These findings are consistent with several earlier studies. Schafer et al 22 studied 81 German men and found in multivariate analysis that the elevated morning leptin concentrations in sleep apneics were completely explained by differences in percent body fat, waist-hip ratio, and subcutaneous neck fat. Similarly, Manzella et al 23 also found no association between leptin levels and OSA severity after controlling for BMI. In contrast to the absolute leptin concentrations, we found that an increased ratio of evening to morning levels was independently associated with both an increased amount of total body fat and an increased AHI. Vgontzas et al 10 also reported that evening levels were greater than morning levels in sleep apneics as opposed to lean controls. They attributed this difference solely to obesity because their obese controls had an evening/morning leptin ratio more similar to that of the apneics than to the ratio of the lean controls. One possible explanation for these discordant findings relates to the timings of the leptin measurements in the 2 studies. Our measurements were performed closer to the typical times for the reported apex and nadir of the diurnal leptin rhythm in previous studies, 24 and so we likely had greater power to detect differences in the leptin rhythm. Additionally, intrinsic population differences are likely. Our sample included a high proportion of African Americans and women. Finally, in order to assess genetic associations in sleep apnea, the ascertainment scheme for our population was designed to increase the prevalence of OSA and to oversample individuals from families with members concordant for levels of AHI. It is possible that by studying a cohort of individuals with a higher familial propensity for OSA, we have enriched the sample with individuals who also have a stronger familial tendency for metabolic abnormalities associated with OSA, potentially enhancing the observed associations of AHI with leptin levels.
Prior studies of leptin and OSA have been largely limited to European American men. We used a cohort of families with a high prevalence of OSA, but with a balanced ethnic and sex mixture, to study the interrelationships of leptin, OSA, and obesity. The relatively high proportion of women (59%), as well as the high frequency of obesity, may explain why average leptin levels in this study were much greater than those reported in previous investigations of leptin in patients with OSA. In addition, nearly half of our cohort was African American, a group that has received little attention in OSA research despite evidence suggesting an increased prevalence and severity of disease relative to European Americans. [25] [26] [27] Despite known differences in leptin biology, body-fat distribution, and OSA across sexes and races, we found the relationship between leptin and OSA to be similar between men and women and between European Americans and African Americans.
Several potential limitations in this study should be noted. Caloric intake prior to this protocol was not standardized. Although feeding does not acutely affect leptin levels, increased caloric consumption over a few days does elevate leptin levels. However, any variability in leptin due to differences in caloric intake is likely nondifferential with respect to OSA severity and therefore is an unlikely explanation for the observed association of OSA with change in overnight leptin levels.
Menstrual phase is also known to affect leptin, with peak leptin levels observed in the luteal phase. Because of the high prevalence of irregular menses in our cohort of women (likely a reflection of their degree of obesity), we could not standardize our timing of data collection to phase of menstrual cycle. Again, because variability in leptin due to differences in menstrual phase at the time of examination would be nondifferential with respect to OSA severity, it is unlikely that systematic biases occurred due to menstrual phase at the time of examination.
Because our analyses were based on cross-sectional data, we cannot define the direction of causality between OSA severity and evening/morning leptin ratio. There are several potential mechanisms by which OSA may alter the diurnal leptin rhythm. Leptin ratio was more strongly associated with the AHI than with measures of oxygenation, the arousal index, or sleep time. Since the AHI is a metric of OSA that provides information on intermittent hypoxemia, arousal, and sleep disruption, we cannot specify which, if any, of these discrete exposures may best predict leptin levels. Another potential mediator is sympathetic activation, which has been found to inhibit leptin release. 28 The heightened nocturnal sympathetic tone caused by the repetitive asphyxic events in OSA may lead to a greater blunting of leptin levels in the morning than in the evening when the relative increase in sympathetic activation between apneics and normal subjects may be less. The change in the diurnal leptin cycle may also be mediated through tumor necrosis factor-α, a potent stimulus of leptin secretion, which has a diurnal rhythm that is also disrupted in sleep apnea. 10, 29, 30 An intriguing alternative possibility is that the elevated evening leptin may have a causal role in the pathogenesis of OSA. Leptin-deficient mice have a blunted hypercapnic ventilatory response, especially during sleep, that normalizes with leptin replacement. 16 Since a high ventilatory drive has been implicated in the pathogenesis of OSA, 31 elevations in leptin levels, by augmenting sensitivity to CO 2 , could contribute to the development of OSA.
Because leptin levels were only measured at 2 time points, we cannot fully describe the diurnal rhythm of leptin in patients with OSA. However, our findings clearly suggest that the leptin rhythm is different between those subjects with and without OSA. Additional work with more frequent sampling is required to better define the difference. Previous studies of diurnal leptin rhythms in normal subjects have found that levels reach their nadir in the late morning and then rise through the afternoon and evening to peak around midnight. 24 The change in ratio associated with OSA may represent a phase advancement in the timing of the nadir, an increase in the amplitude of the diurnal pattern, or a combination of the 2 processes. Changing the timing of the nadir and zenith of leptin levels may lead to alterations in meal timings and overall dietary intake. Changes in the amplitude of cycling may also have important effects. The lower levels during the day may lead to greater caloric intake, which would not be offset by the high levels at night, since sleep already prevents nocturnal food consumption. There has been great interest in the effect of OSA on obesity, with evidence to suggest that OSA causes weight gain and increased visceral obesity. 11, 32 One must be cautious in interpreting the physiologic significance of morning leptin levels that are low relative to evening levels (but nonetheless, generally high). However, it is possible that the relatively lower morning levels, occurring in states of leptin "resistance" may contribute to increased morning appetite and weight gain in individuals with OSA. Further experimental data are needed to directly assess whether altered leptin dynamics is a mechanism by which OSA produces further obesity.
